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Epithelial-mesenchymaltransition(EMT)hasemergedinrecentyearsasanimportantprocessinthedevelopmentoforganﬁbrosis
in many human diseases. Our previous experience in a nonhuman primate model of obstructive nephropathy suggested that EMT
of collecting duct epithelium contributes to the development of interstitial ﬁbrosis. In this study we demonstrate for the ﬁrst
time in humans that obstructed fetal collecting duct epithelium undergoes transition to mesenchymal phenotype, characterized
by decreased expression of epithelial markers, de novo expression of mesenchymal markers with subsequent loss of cell-cell
interaction,disruptionofthebasementmembrane,andincreaseddepositionofextracellularmatrixintotheexpandedinterstitium
of the obstructed kidney. The results of this study therefore support the previous ﬁndings from animal studies and suggest that
EMT of the collecting duct epithelium might contribute to the development of interstitial ﬁbrosis in human fetal obstructive
nephropathy.
1.Introduction
Renal hypoplasia/dysplasia, often associated with obstructive
nephropathy,istheleadingcauseofendstagerenaldiseasein
childhood [1]. Despite advances in diagnosis and antenatal
management of congenital urinary tract obstruction, the
outcomes of these children have not improved since fetal
intervention was introduced into clinical practice over 20
years ago.
Injury to the epithelium in a number of human disease
states causes epithelial cells to acquire mesenchymal charac-
teristics through the process of epithelial-mesenchymal tran-
sition (EMT), and in congenital urinary tract obstruction
thiscontributestothecharacteristictubulointerstitialdisease
[2–7]. The hallmark of renal dysplasia is the accumulation
of extracellular matrix in the interstitium leading to ﬁbrosis.
The injured epithelium plays an important role in this
process.
We have previously studied the pathogenesis of renal
dysplasia in a nonhuman primate model of obstructive
nephropathy [8, 9], and highlighted signiﬁcant histo-
pathological changes in the renal medullary interstitium,
including dilatation of the collecting ducts (CDs), and
disruption of the CD epithelium. We have also deﬁned
features suggestive of CD EMT in this experimental animal
model with loss of the normal epithelial phenotype, gain of a
mesenchymalphenotype,disruption ofthetubularepithelial
basement membrane, and migration of the transformed cells
into the interstitium [10].
The aim of this study was to test the hypothesis that
congenital urinary tract obstruction in humans results in
CD epithelial cell injury and transition to a mesenchymal
phenotype, and that these transformed cells contribute to
interstitial ﬁbrosis.2 Journal of Biomedicine and Biotechnology
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Figure 1: Gestational and postnatal ages of the obstructed and control kidney tissue samples.
2.MaterialsandMethods
2.1. Tissue Samples. Specimens from obstructed and normal
human fetal and postnatal kidneys were studied (total n =
17). Obstructed kidney samples were obtained from fetuses
in the second (18 weeks gestation, n = 2) and third
trimesters (36 weeks gestation, n = 3), and postnatal ages
(16 and 24 months, n = 2). Controls consisted of kidney
samples from fetuses in the late ﬁrst trimester (10 weeks,
n = 1), second trimester (15, 18 and 26 weeks, n = 6),
and third trimester (27 and 36 weeks gestation, n = 2),
and 12 months postnatal age (n = 1) (Figure 1). In all
cases fetuses had no other noted anomalies. Control kidney
samples were obtained from aborted fetuses and children
that died from causes unrelated to renal disease. All samples
werecollectedinaccordancewiththeethicalguidelinesofthe
University of British Columbia, and all performed analyses
were approved by the Ethics Committee of the University of
British Columbia.
2.2. Tissue Processing. After collection, kidneys were sec-
tioned transversely and sagitally then immediately ﬁxed in
4% paraformaldehyde overnight, and dehydrated through
graded ethanol before transfer to toluene. Sections of
paraﬃn-embedded tissue were cut with a microtome (5–
10μm), mounted on Superfrost slides (VWR), and baked
overnight at 55◦C. Sections were then cooled to room
temperature and stored with desiccant. Samples for real-
t i m eP C Rw e r es n a pf r o z e ni nl i q u i dn i t r o g e na n ds t o r e da t
≤− 80◦C.
2.3. Immunoﬂuorescent Histochemistry. Tissue sections were
deparaﬃnized in xylene and rehydrated by passage through
graded ethanol. For light microscopy, sections were stained
withhematoxylinfor2minutesandeosinfor40seconds.For
immunohistochemistry, slides were subjected to 40 minutes
of heat-induced epitope retrieval in 10mM citrate buﬀer
(pH 6–6.5). Sections were subsequently cooled to room
t e m p e r a t u r ea n db l o c k e df o r1h o u rw i t h2 %g o a to rd o n k e y
serum. Following blocking, excess buﬀer was removed from
the sections and replaced with diluted primary antibodies
in staining buﬀer for incubation overnight at 4◦C. Sections
werethenincubatedfor1hourwithﬂuorescentlyconjugated
secondary antibodies at room temperature. Nuclei were also
stained for 5 minutes with DAPI dilactate (1 : 36, Invitrogen)
prior to mounting with Prolong Gold mounting media
with antifade (Invitrogen). Analysis of tissue staining was
performed on a Leica epiﬂuorescence microscope (Wetzlar,
Germany) using images captured with a Retiga 1300i camera
(QImaging, Canada) and processed with OpenLab imaging
software (Improvision, MA, USA). Primary antibodies and
their dilutions were as follows: anticytokeratin (DakoCy-
tomation, Carpinteria, CA), antiE-cadherin (BD Trans-
duction Laboratories, San Diego, CA), antiβ-catenin (Cell
Signalling Technology Danvers, MA), antiα-smooth muscle
actin, anticollagen IV (Fitzgerald Industries International
Inc., Concord, MA), and antivimentin (Sigma-Aldrich, Saint
Louis, MO) (all diluted 1 : 100). Secondary antibodies
included goat antimouse Alexa488, goat antirabbit Alexa568,
and donkey antigoat Alexa568 (Invitrogen Canada Inc.,
Canada) (all diluted 1 : 400). For correlation between
the degree of obstruction, and periductal α-SMA and CD
epithelial vimentin expression, we measured the areas of the
CD dilatation, the areas of α-SMA in periductal collars, and
theareasoftheCDcellsexpressingvimentin(allexpressedin
mm2)inobstructedfetalandpostnatalkidneys(n = 3)using
the OpenLab imaging software. The relationship between
measured areas was expressed as a scatter plot with trend
lines using Microsoft Excel 2008 for Mac.
2.4. Real-Time PCR. Real-time PCR analysis was performed
on total RNA extracted from normal kidneys at 10 weeks
gestation (n = 1), 15 weeks gestation (n = 2), and 18
weeks gestation (n = 1), and obstructed kidneys at 18 weeks
gestation (n = 2) and 36 weeks gestation (n = 1). Total
RNAwasisolatedfromthewholekidneysusingRNeasyMini
Kit protocol (Qiagen Inc., Mississauga, ON, Canada) with
RNA-free DNase treatment before treatment with Power-
Script reverse transcriptase (BD Biosciences, San Jose, CA).
Predesigned TaqMan Gene Expression Assays were used for
thefollowingtargetgenes:E-cadherin(Hs01013953 m1),N-
cadherin (Hs00983062 m1), α-catenin (Hs00426996 m1),Journal of Biomedicine and Biotechnology 3
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Figure 2: Histological features of human fetal obstructive nephropathy. Obstructed 18 weeks gestation kidney shows disorganized cortical
architecture with multiple glomerular cysts (c), decreased glomerular (g) endowment ((b) and (f)), and reduced number and dilation of the
collecting ducts (cd) in the hypoplastic medulla ((d) and (h)). Cortex ((a) and (e)) and medulla ((c) and (g)) of a normal 18-week gestation
kidney. (a)–(d): hematoxylin and eosin stain; (e)–(h) immunoﬂuorescence histochemistry: green = cytokeratin, red = vimentin. Scale bar =
100μm.
β-catenin (Hs00355045 m1), vimentin (Hs00958116 m1),
alpha-3 chain of type IV collagen (Hs01022542 m1),
alpha-4 chain of type IV collagen (Hs01011885 m1), α-
smooth muscle actin (Hs00559403 m1), and cyclophilin A
(Hs99999904 m1) (Applied Biosystems, Foster City, CA).
All samples were ampliﬁed in triplicate on ABI Prism
7000 Sequence Detection System using TaqMan Universal
PCR MasterMix (Applied Biosystems, Foster City, CA).
Optimization and relative quantiﬁcation were done using
the prevalidated comparative CT method. Normalization of
RNA quantity between samples was accounted for using the
expression of the housekeeping gene cyclophilin A. The fold
changeofeachgenebetweensampleswasdeterminedrelative
to control kidney at 18 weeks gestation.
3. Results
3.1. Histological Features of Human Congenital Obstructive
Dysplasia. Congenital urinary tract obstruction was associ-
ated with abnormal ureteric bud branching and defective
metanephricmesenchymeinductionwithsubsequentabnor-
mal collecting duct, tubular, and glomerular development
(Figure 2). All obstructed developing kidneys showed focal
areas of dysplastic and cystic changes. Multiple glomerular
cysts were identiﬁed in both the cortex and the medulla,
whereas cystic dilatation of the renal tubules and CDs
was seen predominantly in the medulla (Figures 2(b) and
2(d)). The most pronounced dysplastic changes were seen
in the medullary regions of the obstructed kidneys where
some areas showed complete loss of normal structure
with dilated CDs surrounded by thick mesenchymal col-
lars. Other histopathological features of dysplasia included
decreased glomerular endowment, reduced number of CDs,
and medullary hypoplasia with interstitial expansion and
interstitial ﬁbrosis. The most dilated CDs were lined with a
ﬂattened epithelium (Figure 2). These changes were present
from early gestation and persisted postnatally.
3.2. Loss of Epithelial Phenotype in the Obstructed Collecting
Duct. The expression of the cytoskeletal proteins E-cadherin
and β-catenin was studied in normal and obstructed
human fetal kidneys. These proteins are important in
normal development of the kidney epithelium [11]a n da r e
responsible for the maintenance of cell polarity, cell-cell
adhesion, and epithelial integrity [12]. In the normal human
CD epithelium, E-cadherin and β-catenin were expressed
early in gestation. Developmentally younger kidneys had
more pronounced cytoplasmic expression of both proteins
(Figure 3(a), inset), whereas kidneys from mid to late
gestation and postnatal kidneys showed colocalization of
E-cadherin and β-catenin at the intercellular junctions of
adjacent CD epithelial cells (Figures 3(b) and 3(c)). In
the obstructed kidneys, the disruption of E-cadherin-β-
catenin colocalization was noted, as well as a loss of E-
cadherin and β-catenin from the cellular membranes, and
the translocation of these proteins into the cytoplasm, with
E-cadherin identiﬁed in the nucleus of the injured CD
epithelial cells (Figures 3(d), 3(e),a n d3(f)).
3.3. Gain of Mesenchymal Phenotype in the Obstructed
Collecting Duct. Injured epithelial cells undergoing EMT
express mesenchymal markers, including ﬁbroblast-speciﬁc
protein-1, α-smooth muscle actin (α-SMA), and vimentin
[13]. We have previously demonstrated de novo α-SMA
expressioninCDepithelialcellsintheobstructednonhuman
primate [10]. These cells contribute to the development4 Journal of Biomedicine and Biotechnology
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Figure3:E-cadherinandβ-cateninimmunoreactivity(IR).Normalkidneys((a)–(c)).(a)Intheearlygestationkidney(10weeks),E-cadherin-
IR (red) and β-catenin-IR (green) are localized in the cytoplasm (arrows). (b) Colocalization of E-cadherin-IR and β-catenin-IR (yellow)
to the intercellular junctions is well established by late gestation (27 weeks) (arrows), and (c) persists in the normal postnatal (12 months)
kidney (arrow). Obstructed kidneys ((d)–(f)). (d) Disruption of E-cadherin-IR and β-catenin-IR colocalization at the intercellular junctions,
with translocation of β-catenin-IR to the cytoplasm (green) and of E-cadherin-IR to the nucleus (red) (arrows in inset) in the (d) mid
gestation kidney (18 weeks), (e) late gestation kidney (36 weeks), and (f) postnatally (16 months kidney). Scale bar = 25μm.
of immature mesenchymal collars surrounding the dilated
ducts. In the human fetal kidneys examined in this study,
the normal CD epithelium did not express α-SMA at any
stage of gestation or postnatally (Figures 4(a), 4(b),a n d
4(c)). However, we observed de novo α-SMA expression
in the obstructed epithelium at mid gestation, but not
later in gestation or postnatally (Figure 4(d)). Mid gestation
obstructed kidneys developed peritubular circumferential
cellular collars expressing α-SMA (Figure 4(d)), becoming
more pronounced as gestation progressed (Figure 4(e)). The
most extensive collars were observed in the inner medulla of
postnatal kidneys (Figure 4(f)) and also in the most severely
obstructed fetal kidneys. The severity of periductular tubular
collar formation correlated with the extent of epithelial
injury and the severity of the obstruction.
Vimentin, a member of the intermediate ﬁlament family
of proteins, oﬀers ﬂexibility to the cell while maintaining
cell shape and cytoskeletal integrity [14]. Under normal
circumstances, diﬀerentiated epithelial cells do not express
appreciable amounts of vimentin, whereas expression of
this protein is a characteristic feature of myoﬁbroblasts. In
normal fetal kidneys, interstitial cells expressed vimentin,
which was most pronounced in younger gestation kidneys,
decreasing in later gestation, and almost absent in postnatal
kidneys (Figures 5(a), 5(b),a n d5(c)). As expected, normal
CD epithelial cells did not express vimentin. However,
obstructed CD epithelial cells showed a very pronounced de
novo expression of vimentin that correlated with the severity
and the duration of the obstruction, increasing from mid
to late gestation and postnatally (Figures 5(d), 5(e),a n d
5(f)). Additionally, obstructed fetal kidneys developed an
expanded interstitium, which expressed abundant vimentin,
compared to normal kidneys of similar gestation. This was
more pronounced in younger kidneys.
3.4. Disruption of the Basement Membrane of the Obstructed
Collecting Duct. Type IV collagen (ColIV) is a major struc-
tural component of all basement membranes, including the
CD basement membrane. ColIV molecules are synthesized
by the cells attached to the basement membrane and are
subsequently incorporated into the membrane itself [15]. In
EMT, the disruption of basement membranes is necessary
to allow the migration of the transformed tubular epithelial
cells [4]. In this study, the CD epithelium of normal kidneys
expressed cytoplasmic ColIV diﬀusely at mid gestation and
apically at late gestation (Figures 5(a) and 5(b)). There was
noepithelialexpressionofColIVinnormalpostnatalkidneys
(Figure 5(c)). Notably, and as expected, all normal fetal
and postnatal kidneys expressed ColIV in the CD basement
membranes in a thin, regular, and well-deﬁned pattern
(Figures 5(a), 5(b),a n d5(c)). In addition to an increase in
apical epithelial cell expression of ColIV, obstructed kidneys
demonstrated a marked disruption of the CD basement
membrane, characterized by thickening, attenuation, and
loss of ColIV expression (Figures 5(d), 5(e), 5(f)). Inter-
estingly, the expanded interstitium of the obstructed fetal
and postnatal kidneys expressed an abundance of ColIV,
most pronounced in the immature mesenchymal collars
surrounding the most dilated CDs, particularly in the inner
medulla of postnatal kidneys, suggesting a correlation with
the severity and duration of the obstruction (Figure 5(f)).Journal of Biomedicine and Biotechnology 5
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Figure 4: E-cadherin and α-smooth muscle actin immunoreactivity. Normal kidneys ((a)–(c)). In the normal mid gestation (18 weeks) (a),
late gestation (27 weeks) (b), and postnatal (12 months) (c) kidneys, α-smooth muscle actin (α-SMA)-IR (green) was absent in the CD
epithelium; however, intercellular localization of E-cadherin-IR (red) was well established from mid gestation onwards (arrows). Obstructed
kidneys ((d)–(f)). Circumferential collars expressing α-SMA-IR (green) are present in the (d) mid gestation (18 weeks), (e) late gestation (36
weeks), and (f) postnatal (16 months) kidneys (arrows). De novo expression of α-SMA-IR in the obstructed CD epithelium is present at 18
weeks gestation ((d) inset, arrowhead) but not in the late gestation (e) or postnatal (f) kidneys. As in Figure 3, E-cadherin expression (red)
is disrupted, with translocation from the cell membrane to cytoplasm ((d)–(f)) and to the nucleus ((e) inset, arrowhead). Scale bar = 25μm.
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Figure 5:VimentinandcollagenIVimmunoreactivity.Normalkidneys((a)–(c)).(a)Interstitialexpressionofvimentin-IR(blue)(arrow)and
diﬀuse cytoplasmic expression of collagen IV (ColIV)-IR (red) (arrowhead) are present in the mid gestation (18 weeks) kidney. (b) Thin,
regular,well-deﬁnedexpressionofColIV-IRintheCDbasementmembranes(arrows)iswellestablishedbylategestation(27weeks),and(c)
persists postnatally (12 months) (arrows). Obstructed kidneys ((d)–(f)). (d) De novo basolateral expression of vimentin-IR (blue) (arrow) in
the CD epithelium of the obstructed 18 weeks gestation kidney. (e) More pronounced vimentin-IR expression (arrowheads) and disruption
of ColIV-IR expression (red) (arrows) in the CD basement membrane of the late gestation (36 weeks) obstructed CD epithelium, and (f) in
the obstructed postnatal (16 months) kidneys. Deposition of ColIV-IR in the expanded interstitium (asterisk), and in the periductal collars
(plus) is also present. Scale bar = 25μm.6 Journal of Biomedicine and Biotechnology
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Figure 6: Correlation of the severity of CD dilatation with periductal collar formation and with CD epithelial vimentin expression.T h e
relationship between CD dilatation (x-axis), and the areas of periductal collars expressing α-SMA (a) and of CD epithelium expressing
vimentin (b) (y-axis) is shown. Measurements were performed in obstructed fetal (36 weeks gestation) and postnatal (16 months) kidneys
(n = 3). All areas are expressed in mm2.
To show the relationship between the severity of obstruc-
tion and the extent of phenotypic transition of the CD
epithelium, we correlated CD dilatation (as a marker of
severity of obstruction) with the expression of α-SMA in
periductalcollarsandofvimentinbytheCDcells(asmarkers
of epithelial injury). CD dilatation correlated with periductal
α-SMA expression and with CD epithelial cell vimentin
expression (Figure 6).
3.5. Gene Expression in Obstructed Fetal Kidneys. Quan-
titative real-time PCR analysis was performed for genes
encoding epithelial and mesenchymal proteins of interest
on total RNA samples obtained from normal (early to mid
gestation) and obstructed (mid to late gestation) whole
kidneys. First, we studied normal changes in gene expression
with advancing gestation. Among genes encoding epithelial
proteins, E-cadherin mRNA expression increased in the 18
versus 10 weeks gestation kidneys, with little change in α-
catenin, β-catenin, and N-cadherin expression (Figure 7(a)).
For genes encoding mesenchymal proteins, vimentin, alpha-
3 and alpha-4 chains of ColIV, and α-SMA were all increased
in the normal 18 weeks compared to 10 weeks gestation
kidney (Figure 7(a)).
We next studied changes in the mRNA expression of
genes encoding epithelial and mesenchymal proteins in
mid (18 weeks) and late gestation (36 weeks) obstructed
kidneys, using the 18-week gestation normal kidney as the
reference control value. Of the genes encoding epithelial
proteins, N-cad expression decreased in the late gestation
obstructed kidney, while α-catenin and β-catenin mRNA
increased (Figure 7(b)). For genes encoding mesenchymal
proteins, vimentin mRNA expression increased with severe
obstruction at 18 and 36 weeks gestation, while mRNAs
for alpha-3, alpha-4 chains of ColIV and for α-SMA were
markedly increased in the severely obstructed 36-week
gestation kidney when compared to the control normal 18
week kidney (Figure 7(b)).
4. Discussion
Epithelial-mesenchymal transition (EMT) and the recip-
rocal mesenchymal-epithelial transition (MET) are central
mechanisms in the development of specialized cells, tissues
and organs from a small variety of pluripotent cells in the
embryo [2, 16]. Experimental evidence that has accumulated
over the last decade supports the role of EMT in the
pathogenesis of many diseases including cancer progression
and metastasis [17], and tissue ﬁbrosis associated with
interstitial lung [18, 19], liver [20], and kidney disease [4,
5, 7]. The role of EMT has been demonstrated in animal
and human studies of postnatal kidney disease, including
acquiredobstructivenephropathy[21],buttherearefewdata
regarding congenital urinary tract obstruction.
Many experimental models of obstructive nephropathy
have been developed [22]. These have provided clues to
the pathogenesis and pathology of this disease. However,
there are some important diﬀerences between the human
congenital forms of obstruction and experimental models.
In human congenital urinary tract obstruction, the timing
of obstruction is often early during in utero nephrogenesis
as opposed to experimental models, such as the sheep and
monkey models, which are mid to late gestation. The best-
described models of ureteric obstruction, the mouse and rat,
are, in fact, postnatal models. In addition, the severity of
obstruction diﬀers. Congenital obstruction can be variable,
from severe and complete to mild and partial obstruction.
Most experimental models are more controlled and there-
fore reproducible. Consequently, the histopathology of the
human forms of congenital obstruction can be variable
(partly due to uncontrollable variability of the timing and
severity of obstruction and partly to the inherent bias of the
availability of tissue) but given the early onset of obstruction,
it is often more severe than that of the experimental forms
of postnatal obstruction, particularly the postnatal rodent
models,asreﬂectedintheseverityofarchitecturaldisruption
and reduction in glomerular number. There are, however,
many histological features shared between both types ofJournal of Biomedicine and Biotechnology 7
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Figure 7: Gene expression in normal and obstructed fetal kidneys. (a) Quantitative PCR analysis of total RNA extracted from 10, 15, and 18
weeksgestationnormalkidneys,forgenesencodingepithelial-speciﬁc(E-cad,N-cad,α-cat,andβ-cat)andmesenchymal-speciﬁc(vimentin,
ColIVa3,ColIVa5andα-SMA)proteins.ValuesareexpressedasfoldchangeinmRNAexpressioncomparedtothenormal10weeksgestation
kidney as reference. (b) Quantitative PCR analysis of total RNA extracted from obstructed kidneys at 18 weeks gestation (mild and severe)
and 36 weeks gestation (severe), and from 18 weeks normal kidney. Values are expressed as fold change in mRNA expression compared to
the normal 18 weeks gestation kidney as reference.
obstruction, most notably human congenital obstruction
and in utero models of obstruction such as the sheep and
monkey models. These features include extensive reductions
in nephron endowment, alterations of tubular and collecting
duct development, collecting duct injury, mesenchymal
expansion, and interstitial ﬁbrosis.
This report, to our knowledge, is the ﬁrst description of
the phenotypic transition of the obstructed CD epithelium
in the human fetus. We have previously described EMT
of the obstructed CD epithelium in a nonhuman primate
model of obstructive nephropathy [10]. Similar to the
obstructed fetal monkey kidney, the major histological
ﬁndings in the obstructed human fetal kidney were cystic
and dysplastic changes particularly in the medulla, with
marked dilatation of the CDs lined by a ﬂattened epithelium.
We also demonstrated many of the prerequisite features of
CD EMT, including the loss of the cytoskeletal proteins E-
cadherin and β-catenin from cell membranes and intercel-
lular junctions, their translocation into the cytoplasm and
nucleus of the obstructed cells, de novo expression of the
myoepithelial proteins vimentin and α-SMA, and disruption
of the obstructed CD epithelial basement membrane. As
documented by immunohistochemistry in this study, from
early gestation, CD cells express epithelial markers (E-
cadherin, β-catenin) in an intercellular distribution typical
of a diﬀerentiated epithelium with minimal expression of
mesenchymal proteins, such as vimentin and α-smooth
muscle actin. These ﬁndings conﬁrm that the cells have
undergoneMET.Thelossofnormaldistributionofepithelial
markers and de novo expression of mesenchymal proteins
by CD cells in obstructed kidneys imply that obstruction
reverses this process. While these ﬁndings may not be
inclusiveofallfeaturesofEMT,theydorepresentatransition
to a more mesenchymal phenotype. Our ﬁndings would
suggest that this transition can occur in cells that have
not terminally diﬀerentiated. We have also shown that CD
dilatation correlated with periductal α-SMA expression and
with CD epithelial cell vimentin expression. While we were
able to demonstrate a clear correlation in the most severely
aﬀected areas, it is important to note that the histopathology
and injury in congenital obstructive nephropathy can be
variable and focal. We observed areas of severe dysplastic
changes alternating with areas of nearly normal histology
within the same obstructed kidney. It is therefore very
diﬃcult to assign any grading to the whole kidney.
The results of real-time PCR analysis show a marked
increase in genes encoding mesenchymal proteins and
minimal changes in genes encoding epithelial proteins in
obstructed kidneys. It should be noted that we used total
RNA extracted from whole kidneys for these experiments.
CD epithelial RNA constitutes only a small fraction of
the whole kidney RNA. The increase in genes encoding
mesenchymalproteinslikelyreﬂectsmesenchymalexpansion
and the formation of periductal collars, measures of whole
kidney ﬁbrosis, with only a small contribution from the
dilated CD epithelial RNA. While the whole kidney ﬁbrosis
may be independent of the parallel changes seen in the
injured CD epithelium, there is experimental evidence
supporting the contribution of the obstructed tubular
epithelium to this process [3]. The minimal changes in genes
encoding epithelial proteins in the obstructed CDs may be
explained again by the relatively small contribution of CD8 Journal of Biomedicine and Biotechnology
Obstruction
ColIV
β-cat
α-cat
E-cad
E-cad
E-cad
β-cat
α-SMA
ColIV
ColIV
α-SMA
VIM
VIM
Figure 8: Paradigm of changes associated with human congenital urinary tract obstruction. The obstruction of the developing kidneys causes
dissociation of the cytoskeletal proteins (E-cadherin, β-catenin) and their translocation to the cytoplasm and the nucleus. Aﬀected cells
become ﬂattened and start expressing mesenchymal markers (vimentin, α-SMA) giving them more ﬂexibility and contractility. Breakdown
of the ductal basement membrane allows the cells to migrate into the interstitium and to contribute to the myoepthelial population of
periductal cells.
RNA relative to total kidney RNA. The other possibility
is that there are minimal changes in RNA levels in the
obstructed CD epithelium, supported by our immunohisto-
chemistry,demonstratingalteredcellularproteinlocalization
rather then a decrease in total protein expression.
The sequence of changes seen in EMT is very similar
irrespective of the organ involved. The earliest epithelial
responses to injury include the loss of intercellular adhesion
molecules (E-cadherin, ZO-1) and dissociation of these
and other structural anchoring molecules (catenins) from
the cytoskeleton of the cell leading to a detachment of
the cells from each other, and to their loss of polarity.
Reorganization of the actin cytoskeleton, conversion of
cytokeratin to vimentin, and de novo expression of α-smooth
muscle actin, the main features of transition into a myoﬁ-
broblastic phenotype, provide the transitioning cells with
more ﬂexibility and mobility. Vimentin oﬀers the cells more
ﬂexibility while maintaining the cell shape and the position
oforganellesinthecytoplasm[23].α-SMAprovidesnotonly
structural support but also the element of contractility that
can help in the invasiveness of the transformed cells [24].
Breakdown of type IV collagen and laminin in the tubular
basement membrane opens the path for these invasive cells
to enter the interstitium and become interstitial ﬁbroblasts
[24, 25]. The ﬁnal nonspeciﬁc pathway of this process
is the development of tissue ﬁbrosis and destruction of
tissue architecture, leading to organ dysfunction and failure
(Figure 8). On the other hand, if the disease process is inter-
rupted, phenotypically transformed cells can rediﬀerentiate
back into epithelial cells and contribute to the tissue repair,
thus undergoing so-called epithelial-mesenchymal-epithelial
cycling [26].
5. Conclusion
This study describes the phenotypic changes in human
congenital obstructive nephropathy. It represents another
step in our understanding of the pathogenesis of thisJournal of Biomedicine and Biotechnology 9
disease and brings us closer to the identiﬁcation of the key
genes/proteins that play an important role in this condition.
Elucidating the role of the individual proteins in EMT will
guide the development of targeted treatments to reverse
tissue ﬁbrosis and eventually prevent the damage of the
aﬀected organ.
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